| abstract |
Provided is an oral composition that stably contains an anti-inflammatory ingredient, which is tranexamic acid or ε-aminocaproic acid, and that produces an excellent mouth-odor prevention effect. The oral composition comprises (A) tranexamic acid or ε-aminocaproic acid, (B) copper ions or zinc ions, and (C) sodium monofluorophosphate, the content of the component (C) being 0.8-3 mass%. |